Evidence map›Paper›PMID 25852859›Full record

ReviewClinical kidney journal2014

HIV medication-based urolithiasis.

Hassane Izzedine, François Xavier Lescure, Fabrice Bonnet

Open access · hybridAbstract readReview
In one paragraph

Review in Clinical kidney journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Guideline
  2. The value of preoperative CD4BMC infectious diseases · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Kidney Disease in HIV Infection.Journal of clinical medicine · 2019
    Review
  11. Renal stone composed of ritonavir.BMJ case reports · 2019
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Kidney stones.Nature reviews. Disease primers · 2016
    Review
  17. Article
  18. Article
  19. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Hassane IzzedineDepartment of Nephrology , Pitie Salpetriere Hospital , Paris , France.
François Xavier LescureDepartment of Infectious and Tropical Diseases , Bichat-Claude Bernard Hospital, APHP Paris , Paris , France ; ATIP/AVENIR U738 INSERM Université Paris Diderot , Paris , France.
Fabrice BonnetCHU de Bordeaux, Department of Internal Medicine and Infectious Diseases , and University Bordeaux Segalen University, INSERM U 897 , Bordeaux 33000 , France.
Centre Hospitalier Universitaire de Bordeaux · FRDélégation Paris 7 · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced renal calculi represent 1-2% of all renal calculi. In the last decade, drugs used for the treatment of HIV-infected patients have become the most frequent cause of drug-containing urinary calculi. Among these agents, protease inhibitors (PIs) are well known to induce kidney stones, especially indinavir and atazanavir, and more recently darunavir. Urolithiasis attributable to other PIs has also been reported in clinical cases such as those during non-PI use. Antiretroviral drug-induced calculi deserve consideration because most of them are potentially preventable. This article summarizes the diagnosis, epidemiology, prevention and management of antiretroviral drug-induced urolithiasis.

Indexed as

antiretroviralHIVrenal failureurolithiasis

Identifiers

PMID25852859
PMCPMC4377784
OpenAlexW2118596773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.